Catalyst
Slingshot members are tracking this event:
Amgen (AMGN) submits Biologics License Application (BLA) to FDA for ABP 980, a treatment for breast cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMGN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 31, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Abp-980, Bla, Fda Review, Breast Cancer
